U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07328906) titled 'STEROID TREATMENT TO PREVENT THORACIC ENDOVASCULAR AORTIC REPAIR POSTIMPLANTATION SYNDROME' on Dec. 27, 2025.
Brief Summary: Postimplantation syndrome (PIS) is a common and clinically important complication following thoracic endovascular aortic repair (TEVAR). PIS is characterized by a strong systemic inflammatory response to the stent-graft implantation and is manifested by flu-like symptoms, which include fever, increased white blood count, increased levels of acute phase proteins, and fatigue, but without a clear inflammatory and infective cause. Besides, it has been demonstrated that PIS is associated with prolonged hospital st...